FDA expected to allow mix ‘n’ match COVID-19 vaccines
Oct 19, 2021
The agency will not recommend one vaccine over another but may say that it is preferable to use same booster as the vaccine.
Fourth COVID-19 shot beneficial in patients with autoimmune rheumatic diseases
Nov 28, 2023
A fourth dose reduces the risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs.
FDA panel recommends approval of Johnson & Johnson booster shot
Oct 15, 2021
The booster shot is recommended for anyone 18 years and older, to be given at least two months after the first dose.
Updated booster shots, not original COVID-19 vaccines, should be standard: FDA panel
Jan 27, 2023
Committee members also weighed a proposal to streamline the dosing schedule for COVID-19 vaccines by turning them into annual shots.
Vaccination seems less protective against transmission of delta variant
Jan 07, 2022
The reduction in transmission of SARS-CoV-2 associated with COVID-19 vaccination was smaller for the delta variant versus the alpha variant.
Biden administration to offer second COVID-19 boosters to those 50+
Mar 28, 2022
Although a second booster for older adults will be offered, federal health officials will not go so far as to recommend it.
Vaccine makers already testing their shots against omicron variant
Nov 29, 2021
So far, existing vaccines have proven effective against prior coronavirus variants, including the delta variant.
COVID-19 vaccine effectiveness changing with delta predominance
Sep 14, 2021
Vaccine protection against SARS-CoV-2 infection declined; protection remained higher against hospitalization, death.
Antibody levels after COVID-19 vaccination inversely linked to body weight
May 23, 2022
An inverse correlation was sustained for up to six months following two doses of BNT162b2 (Pfizer–BioNTech) in a small cohort of healthy young and middle-aged adults.
mRNA vaccines effectively prevent SARS-CoV-2 in adults in real-world setting
Jul 01, 2021
For those with SARS-CoV-2 infection, vaccinated participants had a lower mean viral load, risk of febrile symptoms and illness duration.